Promising Developments and Strategic Collaborations Bolster Buy Rating for Olema Pharmaceuticals
Analyst Sam Slutsky from LifeSci Capital maintained a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) and keeping the price ...